Details

Autor(en) / Beteiligte

• Chu, Kwan Yi
• Lau, Tung
• Carlsson, Per-Ola
• Leung, Po Sing

Titel

Angiotensin II Type 1 Receptor Blockade Improves β-Cell Function and Glucose Tolerance in a Mouse Model of Type 2 Diabetes

Ist Teil von

• Diabetes (New York, N.Y.), 2006-02, Vol.55 (2), p.367-374

Ort / Verlag

Alexandria, VA: American Diabetes Association

Erscheinungsjahr

2006

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Angiotensin II Type 1 Receptor Blockade Improves β-Cell Function and Glucose Tolerance in a Mouse Model of Type 2 Diabetes Kwan Yi Chu 1 , Tung Lau 1 , Per-Ola Carlsson 2 and Po Sing Leung 1 1 Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China 2 Departments of Medical Cell Biology and Medical Sciences, Uppsala University, Uppsala, Sweden Address correspondence and reprint requests to Professor P. S. Leung, PhD, Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. E-mail: psleung{at}cuhk.edu.hk Abstract We identified an angiotensin-generating system in pancreatic islets and found that exogenously administered angiotensin II, after binding to its receptors (angiotensin II type 1 receptor [AT1R]), inhibits insulin release in a manner associated with decreased islet blood flow and (pro)insulin biosynthesis. The present study tested the hypothesis that there is a change in AT1R expression in the pancreatic islets of the obesity-induced type 2 diabetes model, the db/db mouse, which enables endogenous levels of angiotensin II to impair islet function. Islets from 10-week-old db/db and control mice were isolated and investigated. In addition, the AT1R antagonist losartan was administered orally to 4-week-old db/db mice for an 8-week period. We found that AT1R mRNA was upregulated markedly in db/db islets and double immunolabeling confirmed that the AT1R was localized to β-cells. Losartan selectively improved glucose-induced insulin release and (pro)insulin biosynthesis in db/db islets. Oral losartan treatment delayed the onset of diabetes, and reduced hyperglycemia and glucose intolerance in db/db mice, but did not affect the insulin sensitivity of peripheral tissues. The present findings indicate that AT1R antagonism improves β-cell function and glucose tolerance in young type 2 diabetic mice. Whether islet AT1R activation plays a role in the pathogenesis of human type 2 diabetes remains to be determined. AT1R, angiotensin II type 1 receptor KRBB, Krebs-Ringer bicarbonate buffer OGTT, oral glucose tolerance test RAS, renin-angiotensin system Footnotes Accepted November 10, 2005. Received August 8, 2005. DIABETES